Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Concerning Immune checkpoint inhibitors (ICIs) & Thromboembolism / Thrombosis, findings suggest potential underreporting of Venous Thromboembolism (VTE) incidence in ICI clinical trials. As dual-ICI is becoming more prevalent in cancer management, clinicians should maintain vigilance regarding Venous Thromboembolism (VTE) in patients with advanced cancer on ICI-based regimens.
Immune checkpoint inhibitors (ICIs) are associated with a high incidence of Thromboembolism / Thrombosis in patients with melanoma, with higher rates with combination therapy; Thromboembolism / Thrombosis is …